Lymphedema, Low-grade Inflammation and the Vasculature in Turner Syndrome

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-100
SponsorUniversity of Aarhus

About this trial

100 women with karyotype verified TS, previously examined at 4 study visits during a 19-year period will be asked to participate in a 5th study visit. Healthy age-matched females will be included as controls in a ratio 2:1.

The aim is to examine and quantify the cardiovascular and lymphatic system in women with TS. The investigators will study a possible causal mechanism between the known pathologic phenotype and alterations in these systems to understand, prevent or treat the life-threatening complications in TS.

Eligibility criteria

Qualifiers

Turner Syndrome

Disqualifiers

pregnancy

contraindications for MRI

Trial design

Treatments tested in this trial

  • No intervention other than obtaining biopsies
  • Indocyanine green (ICG)

Treatment groups

150 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Aarhus

Lead sponsor

Aarhus University Hospital

Collaborator